期刊文献+

他汀类药物在缺血性脑血管病二级预防中的疗效观察

The curative effect observation of statins in secondary prevention of ischemic cerebrovascular disease
下载PDF
导出
摘要 目的观察他汀类药物在缺血性脑血管病二级预防中的作用。方法将59例患者随机分成治疗组和对照组,进行2年跟踪观察。治疗组给予阿司匹林加他汀类口服,对照组给予阿司匹林口服。结果治疗组缺血性脑血管病复发率明显低于对照组。结论他汀类药物在缺血性脑血管病二级预防中起重要作用。 Objective To estimate the role of statins in secondary prevention of ischemic cexebrovaseutar disease. Methods Fifty-nine patiens of ischemie cerebrovascular disease were randomized to control and therapy group, followed for two years. Aspirin and statins were administered to the therapy group, aspirin without statins to the control. Results The recurrence in the therapy group was significant lower than in the control group. Conclusion Statins is important in secondary prevention of ischemic cerebrovascular disease.
作者 黄忠卫
出处 《中国临床新医学》 2008年第B12期57-58,共2页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词 缺血性脑血管病 二级预防 他汀类 Ischemic cerebrovascular disease Secondary prevention Statins
  • 相关文献

参考文献1

二级参考文献15

  • 1Stepp DW, Ou J, Ackerman AW, et al. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am J Physiol Heart Circ Physiol,2002 ;283 :H750-759.
  • 2Ou J,Ou Z,Jones DW,et al. L-4F,an apolipoprotein A-1 mimetic,dramatically improves vasodilation in hypercholestemlemia and sickle cell disease. Circulation ,2003,107:2337-2341.
  • 3Mason RP,Walter MF,Jacob RF. Effects of HMG-CoA reductase inhibitors on endothelial function : role of microdomains and oxidative stress.Circulation,2004,109 ( Suppl 1 ) : Ⅱ34-41.
  • 4Wassmann S, Laufs U, Stamenkovic D, et al. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation,2002,105:2053-2091.
  • 5Feron O, Dessy C, Desager JP,et al. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation, 2001,103 : 113-118.
  • 6Walter MF, Jacob RF,Jeffers B, et al. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease:a longitudinal analysis of the PREVENT study.J Am Coll Cardiol ,2004 ,44 :1996-2002.
  • 7Wassmann S, Laufs U, Muller K, et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol,2002,22:300-305.
  • 8Van Wissen S,Trip MD,Smilde TJ,et al. Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy. Atherosclerosis ,2002,165 : 361-366.
  • 9Wiklund O, Mattsson-Hulten L, Hurt-Camejo E, et al. Effects of simvastatin and atorvastatin on inflammation markers in plasma. J Intern Med 2002,251:338-347.
  • 10Nissen SE,Tuzcu EM, Schoenhagen P, et al. for the REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA ,2004,291 : 1071-1080.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部